Wiegering, Verena <br/><br/>
Impaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia.  [electronic resource] 

 -  Leukemia & lymphoma  Apr 2014 
 - 870-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2013.816423  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--therapeutic use<br/>B-Cell Activating Factor--metabolism<br/>B-Lymphocyte Subsets--immunology<br/>Biomarkers--metabolism<br/>Child<br/>Child, Preschool<br/>Daunorubicin--therapeutic use<br/>Female<br/>Flow Cytometry<br/>Follow-Up Studies<br/>Humans<br/>Immunophenotyping<br/>Infant<br/>Killer Cells, Natural--immunology<br/>Male<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Prednisone--therapeutic use<br/>T-Lymphocyte Subsets--immunology<br/>Treatment Outcome<br/>Vincristine--therapeutic use